New hope for kids with Hard-to-Treat TB: bedaquiline combo under study
NCT ID NCT02354014
First seen Sep 30, 2025 · Last updated May 08, 2026 · Updated 26 times
Summary
This study is testing a drug called bedaquiline (TMC207) in children and teens (0 to 18 years old) who have multidrug-resistant tuberculosis (MDR-TB). The goal is to see how safe the drug is, how the body processes it, and how well it works when given with other TB medicines. About 60 participants will take the drug combination and be monitored for side effects and treatment success.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIDRUG-RESISTANT TUBERCULOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
De La Salle Health Sciences Institute- DLSUMC
RECRUITINGDasmariñas, 4114, Philippines
-
Desmond Tutu TB Centre
RECRUITINGStellenboch, 7600, South Africa
-
First Moscow State Medical University n.a. I.M. Sechenov
COMPLETEDMoscow, 119991, Russia
-
Hospital Geral da Polana Caniço
RECRUITINGMaputo, 00000, Mozambique
-
Lung Center Of The Philippines
COMPLETEDQuezon City, 1100, Philippines
-
Makerere University Lung Institute
TERMINATEDKampala, Uganda
-
Silang Specialists Medical Center
RECRUITINGSan Vincent Silang, 000, Philippines
-
Sizwe Tropical Diseases Hospital
RECRUITINGJohannesburg, 2131, South Africa
-
State Institute Of Phthisiology And Pulmonology N.A. F.G. Yanovskiy Of Ams Ukraine
COMPLETEDKiev, 3038, Ukraine
-
THINK: Tuberculosis & HIV Investigative Network
COMPLETEDDurban, 4001, South Africa
-
Wits Health Consortium
RECRUITINGPort Elizabeth, 6200, South Africa
Conditions
Explore the condition pages connected to this study.